Mexico Urology Devices Market (2025-2030)
The Mexico Urology Devices Market was valued at $839.9 Million in 2025 and projected to reach to $1049.3 Million by 2030, representing a compound annual growth rate of 4.6%. Mexico's urology devices market is positioned for sustained growth through 2030, supported by demographic shifts toward an aging population with higher urological disease incidence.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Mexico Urology Devices Market Trends and Insights
- Mexico's market expansion is driven by increasing prevalence of urological conditions, rising healthcare expenditure, and growing adoption of minimally invasive surgical technologies across the country.
- The market in Mexico reflects broader Latin American trends toward modernization of medical infrastructure and improved patient access to advanced diagnostic and therapeutic devices. Key growth factors in Mexico include an aging population with higher incidence of benign prostatic hyperplasia and urinary incontinence, coupled with strengthening private healthcare sectors in major urban centers.
- Mexico's urology devices market benefits from increasing awareness of treatment options and improving reimbursement policies that support device adoption.
- Between 2025 and 2030, Mexico is expected to see sustained demand for urological interventions, positioning the country as a significant market within Latin America's healthcare landscape..
Key Market Statistics
- CAGR (2025-2030) 4.6% CAGR
- Market Size, 2025 ~USD 839.9 Million
- Forecast, 2030 ~USD 1049.3 Million
- Country Mexico
Mexico Urology Devices Market Overview
Market Size & Growth :
Mexico's urology devices market is valued at USD 839.9 million in 2025, with projected growth to USD 1,049.3 million by 2030, reflecting a steady CAGR of 4.6% driven by healthcare modernization.
Rising Urological Disease Burden :
Increasing prevalence of urological conditions including benign prostatic hyperplasia, kidney stones, and urinary incontinence across Mexico's aging population is fueling demand for diagnostic and therapeutic devices.
Minimally Invasive Technology Adoption :
Growing adoption of minimally invasive surgical technologies in Mexican healthcare facilities is reshaping treatment paradigms, reducing patient recovery times, and driving demand for advanced urology devices.
Healthcare Expenditure Expansion :
Rising healthcare spending and improved insurance coverage in Mexico are enabling greater access to urology devices and procedures, particularly in urban and semi-urban medical centers.
Mexico Urology Devices Market Dynamics
- Healthcare infrastructure investments and increasing physician adoption of advanced diagnostic and therapeutic technologies are creating favorable conditions for market expansion.
- The shift toward minimally invasive procedures aligns with global best practices and patient preferences for reduced morbidity. Key growth catalysts include expanding private healthcare networks, rising medical tourism, and government initiatives to improve urological care accessibility.
- However, market penetration remains below developed nations, presenting significant untapped opportunities.
- Competitive pricing pressures and regulatory compliance requirements will shape market dynamics, while partnerships between international device manufacturers and local distributors are expected to accelerate market development through 2030..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Mexico's urology devices market is valued at USD 839.9 million in 2025 and will reach USD 1,049.3 million by 2030 at a 4.6% CAGR.
- Mexico's aging population and rising prevalence of urological disorders are primary drivers of market growth through 2030.
- Minimally invasive surgical technologies and improved reimbursement policies are accelerating device adoption across Mexico.
- Mexico's private healthcare sector expansion is creating new opportunities for urology device manufacturers and distributors.
Urology Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | URINARY INCONTINENCE (UI) (Application) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6% from 2025 to 2030 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 34.57 (2025) |
| Revenue Forecast (Billions) | ~USD 46.26 (2030) |
| Segments Covered | Product, Type, Application, End User |
Mexico Urology Devices Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product
- Consumables & Accessories
- Instruments
By Type
- Biopsy Devices
- Catheters
- Cystoscopes
- Dialysis Consumables
- Dialysis Devices
- Dilator Sets & Urethral Access Sheaths
- Drainage Bags
- Endoscopes
- Endoscopy Fluid Management Systems
- Endovision & Imaging Systems
- External Catheters
- Guidewires
- Hemodialysis Devices
- Indwelling/ Foley Catheters
- Insufflators
- Intermittent Catheters
- Laparoscopes
- Laser & Lithotripsy Devices
- Nephroscopes
- Other Consumables & Accessories
- Other Instruments
- Peritoneal Dialysis Devices
- Resectoscopes
- Retrieval Devices & Extractors
- Robotic Systems
- Stents And Implants
- Surgical Dissectors, Forceps & Needle Holders
- Tubes & Distal Attachments
- Ureteroscopes
- Urodynamic Systems
By Application
- Benign Prostatic Hyperplasia (Bph)
- Erectile Dysfunction
- Kidney Diseases
- Other Applications
- Pelvic Organ Prolapse
- Urinary Incontinence (Ui)
- Urinary Stones
- Urological Cancer
By End User
- Ambulatory Surgery Centers
- Clinics
- Dialysis Centers
- Home Care Settings
- Hospitals
MEXICO: UROLOGY DEVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGERY CENTERS | 45.6 | 45.5 | 45.4 | 46.2 | 47.5 | 49.1 | 51.3 | 54.5 | 3.7 |
| CLINICS | 20.5 | 20.3 | 20.1 | 20.4 | 20.8 | 21.4 | 22.2 | 23.4 | 3.1 |
| DIALYSIS CENTERS | 160.4 | 162.8 | 165.4 | 171.5 | 179.2 | 188.9 | 200.8 | 217.2 | 5.6 |
| HOME CARE SETTINGS | 127.8 | 129.1 | 130.5 | 134.6 | 140 | 146.8 | 155.3 | 167.1 | 5.1 |
| HOSPITALS | 476.4 | 477.2 | 478.5 | 489.6 | 504.6 | 524.7 | 550 | 587.1 | 4.2 |
| TOTAL | 830.7 | 834.9 | 839.9 | 862.3 | 892.1 | 930.9 | 979.6 | 1049.3 | 4.6 |
Target Audience
- Medical Device Manufacturers : Global and regional urology device manufacturers require Mexico-specific market intelligence to evaluate market potential, develop localized strategies, and identify partnership opportunities for market penetration.
- Healthcare Investors & PE Firms : Investment firms evaluating healthcare opportunities in Latin America need detailed Mexico market data to assess growth potential, competitive dynamics, and return on investment for urology device companies.
- Hospital & Healthcare Facility Operators : Mexican hospital networks and private healthcare providers need market insights to guide capital equipment procurement decisions, technology adoption planning, and service line development in urology.
- Distributors & Healthcare Suppliers : Medical device distributors and healthcare suppliers operating in Mexico require market forecasts and segment analysis to optimize inventory management, supplier relationships, and sales strategies.
- Healthcare Consultants & Analysts : Management consultants and healthcare analysts advising clients on Mexico market expansion need validated market data, growth projections, and competitive insights to support strategic recommendations.
Key Companies in the Mexico Urology Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| SIEMENS HEALTHINEERS | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| NOVANTA, INC | United States | Public Company | Precision Medicine and Manufacturing (lasers, beam steering, robotic motion, end-of-arm tooling, spindles),Medical Solutions (insufflators, pumps, disposables, imaging, RFID, light engines, OR integration), |
| LUMENIS LTD | Israel | Private Company | Surgical,Ophthalmic,Aesthetic, |
| MERIT MEDICAL | United States | Public Company | Cardiovascular (cardiac and peripheral intervention, access, hemostasis, fluid and hemodynamic management),Oncology and Spine (soft tissue biopsy, vertebral augmentation, RFA, bone biopsy),Endoscopy (gastroenterology and pulmonary, including stents, cryoballoon, dilators, kits), |
| FRESENIUS MEDICAL CARE AG & CO. KGAA | Germany | Public Company | Care Delivery (dialysis clinics and services),Dialysis equipment and disposables,Renal pharmaceuticals and ancillary services, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, CRM, electrophysiology, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health, |
| B. BRAUN MELSUNGEN AG | Germany | Private Company | Infusion therapy and smart infusion management,Sterile processing, OR supply, and surgical asset management,Standard and customized procedure kits, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (med-surg disposables, injection, vascular access, sharps),Connected Care (infusion, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems), |
| OLYMPUS CORPORATION | Japan | Public Company | Gastrointestinal Solutions,Surgical Endoscopes & Integrated OR,Urology Solutions, |
| CARDINAL HEALTH | United States | Public Company | Branded Pharmaceutical Distribution,Generic and OTC Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services, |
| INTUITIVE SURGICAL | United States | Public Company | da Vinci systems (capital),da Vinci instruments, accessories, and stapling/energy,Ion endoluminal system and accessories, |
| COLOPLAST A/S | Denmark | Public Company | Ostomy Care (SenSura Mio, SenSura, Brava),Continence Care (SpeediCath, Conveen, Peristeen),Advanced Wound Dressings and Biologics (Biatain, Comfeel), |
| STRYKER | United States | Public Company | Orthopaedics (hips, knees, shoulders, ankle, trauma and extremities, Mako Shoulder-linked implants),MedSurg equipment and patient handling (surgical equipment, patient and caregiver safety, emergency and ICU disposables),Neurotechnology and stroke care (navigation, endoscopy, stroke and venous thromboembolism treatment, brain and skull procedures), |
| TELEFLEX INCORPORATED | United States | Public Company | Vascular and Emergency Medicine (Arrow, EZ-IO, FAST1, QuikClot),Interventional (coronary, structural heart, peripheral, closure, OnControl),Surgical (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS), |
| CONVATEC GROUP PLC | United Kingdom | Public Company | Advanced Wound Care,Ostomy Care,Continence Care, |
| MEDTRONIC PLC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes), |
SIEMENS HEALTHINEERS
Siemens Healthineers is a German public company founded in 1896 with 72,369 employees, operating in the healthcare technology sector.
NOVANTA, INC
Novanta, Inc. is a United States-based public company founded in 1968 with 3,000 employees.
LUMENIS LTD
Lumenis Ltd. is an Israeli private company founded in 1991 with 954 employees.
MERIT MEDICAL
Merit Medical is a United States-based public company founded in 1987 with 7,500 employees.
FRESENIUS MEDICAL CARE AG & CO. KGAA
Fresenius Medical Care AG & Co. KGaA is a German public company founded in 1996 with 108,165 employees, operating as a major healthcare provider.
BOSTON SCIENTIFIC CORPORATION
Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees, specializing in medical devices.
B. BRAUN MELSUNGEN AG
B. Braun Melsungen AG is a German private company founded in 1839 with 61,583 employees, operating in the medical and pharmaceutical sectors.
BECTON, DICKINSON AND COMPANY
Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees, specializing in medical technology and diagnostics.
OLYMPUS CORPORATION
Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees, operating in imaging and medical technology.
CARDINAL HEALTH
Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees, operating as a healthcare services and products distributor.
INTUITIVE SURGICAL
Intuitive Surgical is a United States-based public company founded in 1995 with 17,021 employees, specializing in robotic surgical systems.
COLOPLAST A/S
Coloplast A/S is a Danish public company founded in 1954 with 17,083 employees, specializing in medical devices and healthcare products.
STRYKER
Stryker is a United States-based public company founded in 1941 with 56,000 employees, operating in medical technology and surgical equipment.
TELEFLEX INCORPORATED
Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees, specializing in medical devices.
CONVATEC GROUP PLC
ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees, operating in medical technology and healthcare products.
MEDTRONIC PLC
Medtronic PLC is an Ireland-based public company founded in 1949 with 95,000 employees, operating as a global leader in medical technology.
Reasons to Buy this Report
- Market Entry Strategy Development : Comprehensive Mexico-specific data enables device manufacturers to develop targeted market entry strategies, identify distribution partnerships, and optimize product positioning for the Mexican healthcare landscape.
- Competitive Intelligence : Detailed insights into Mexico's urology device market dynamics, key players, and growth drivers provide competitive advantage for stakeholders planning investments or expansion in this emerging market.
- Investment Decision Support : Validated market size projections and CAGR forecasts through 2030 support informed investment decisions, business case development, and resource allocation for Mexico-focused healthcare initiatives.
- Regulatory & Reimbursement Insights : Mexico-specific analysis of healthcare regulations, reimbursement frameworks, and compliance requirements helps manufacturers navigate market entry barriers and optimize commercialization strategies.
- Growth Opportunity Identification : Identification of high-growth segments, underserved patient populations, and emerging technology adoption trends in Mexico enables strategic focus on the most profitable market opportunities.
Frequently asked questions
What is the current size of Mexico's urology devices market?
Mexico's urology devices market is estimated at USD 839.9 million in 2025.
What is the projected market size for Mexico's urology devices by 2030?
Mexico's urology devices market is projected to reach USD 1,049.3 million by 2030.
What is the CAGR for Mexico's urology devices market?
Mexico's urology devices market is expected to grow at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2030.
What are the main drivers of growth in Mexico's urology devices market?
Key drivers include an aging population, increasing prevalence of urological conditions, rising healthcare expenditure, adoption of minimally invasive technologies, and improving reimbursement policies in Mexico.
Which segments are growing fastest in Mexico's urology devices market?
Minimally invasive surgical devices and diagnostic equipment are among the fastest-growing segments in Mexico's urology devices market due to technological advancement and increased clinical adoption.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global urology devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, World Health Organization (WHO), US Food and Drug Administration (US FDA), National Center for Biotechnology Information (NCBI), Health Canada, European Medicines Agency (EMA), and Centers for Disease Control and Prevention (CDC). These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urology devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Urology Devices Market : Top-Down and Bottom-Up Approach
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Urology is a medical specialty that deals with the physiology, diseases, and disorders of the human urinary tract and male reproductive organs. Urology devices comprise various types of equipment used during the diagnosis, surgery, and treatment of urological diseases, such as chronic kidney diseases, renal failure, urinary stones, benign prostate hyperplasia (BPH), pelvic organ prolapse (POP), prostate cancer, kidney cancer, bladder cancer, and erectile dysfunction.
Key Stakeholders
- Manufacturers and Distributors of Urology Devices
- Hospitals and ASCs
- Academic Research Institutes
- Urology Clinics
- Urology Device Service Providers
- Venture Capitalists and Investors
- Clinical Research Organizations (CROs)
Report Objectives
- To define, describe, and forecast the urology devices market by product, application, end user, and region
- To forecast the size of the urology devices market with respect to five regional segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall urology devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile the key players in the urology devices market and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
- To track and analyze competitive developments such as product launches, product approvals, mergers, agreements, collaborations, partnerships, expansions, and acquisitions in the urology devices market
- To benchmark players within the urology devices market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the urology devices market
Customization Options
With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment
- Product Matrix gives a detailed comparison of the product portfolios of the top five companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Geographical Analysis
- A further breakdown of the Rest of Europe’s urology devices market into countries
- A further breakdown of the Rest of Asia Pacific’s urology devices market into countries
- A further breakdown of Latin America’s urology devices market into countries
Get the Full Urology Devices Market Report
Full forecast, segment splits, and company analysis for all Urology Devices Market.
- US Urology Devices Market
- Canada Urology Devices Market
- Germany Urology Devices Market
- UK Urology Devices Market
- France Urology Devices Market
- Italy Urology Devices Market
- Spain Urology Devices Market
- China Urology Devices Market
- Japan Urology Devices Market
- India Urology Devices Market
- Brazil Urology Devices Market
- Rest Of Europe Urology Devices Market
- Rest Of Asia Pacific Urology Devices Market
- Rest Of Latin America Urology Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report